Dialysis of the rectum for sampling drug concentrations in the luminal extracellular fluid of the gut: Technique and precision

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 7, 1998, Pages 679-684

  Egan, L J ^a   Sandborn, W J ^a   Mays, D C ^a   Tremaine, W J ^a   Lipsky, J J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ACCURACY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DIALYSIS MEMBRANE; DIFFUSION; DRUG BIOAVAILABILITY; ENTERITIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; ISOTOPE LABELING; LIQUID SCINTILLATION COUNTING; PRIORITY JOURNAL; PROPRIOCEPTION; RECTUM; SUBCUTANEOUS DRUG ADMINISTRATION; TECHNIQUE;

ANTIRHEUMATIC AGENTS; DIALYSIS; HALF-LIFE; HUMANS; INFLAMMATORY BOWEL DISEASES; LINEAR MODELS; MALE; METHOTREXATE; RECTUM;

EID: 0031845327     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00352.x     Document Type: Article

References (16)

1. Sandborn WJ. Goldman DH. Lawson GM. Perrault J. Measurement of colonic tissue cyclosporine concentration in children with severe ulcerative colitis. J Ped Gstroenterol Nutr 1992; 15: 125-9.
2. Sandborn WJ. Tremaine WJ. Lawson GM. Clinical response does not correlate wilh intestinal or blood cyclosporine concentrations in patients with Crohn's disease treated with high-dose oral cyclosporine. Am J Gastroenterol 1996; 91: 37-43.
3. Wrong O. Morrison RBI. Hursl PE. A method of obtaining faecal fluid by in vivo dialysis. Lancet 1961; i: 1208-9.
4. Wrong O. Metcalfe-Gibson A, Morrison RBI. Ng ST. Howard AV. In vivo dialysis of faeces as a method of stool analysis. I. Technique and results in normal subjects. Clin Sci 1965; 28: 357-75.
5. Lauritsen K. Hansen J. Bytzer P. Bukhave K. Rask-Madsen J. Effects of sulfasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls. Gut 1984; 25: 1271-8.
6. Lauritsen K. Hansen J. Ryde M. Rask-Madsen J. Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis. Gastroenterology 1984; 86: 1496 500.
7. Lauritsen K. Laursen LS. Bukhave K. Rask-Madsen J. Effects of topical 5-aminosalicylic acid and prednisolone on prostagelandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986; 91: 837-44.
8. Kazi N. Fields JZ, Sedghi S. et al. Modulation of neutrophil function by novel colonic factors: possible role in the pathophysiology of ulcerative colitis. J Laboratory Clin Med 1995; 126: 70-80.
9. Stenson WF, Cort D, Rodgers J. et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992:; 116: 609-14.
10. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis. Crohn's colitis, and Clostridium difficile colitis. Gastroenterology 1988; 95: 11-17.
11. Egan LJ. Sandborn WJ, Tremaine WJ. et al. A randomized, single blind, pharmacokinetic and dose response study of subcutaneous methotrexate, 15 and 25 mg/week, for refractory ulcerative colitis and Crohn's disease. Gastroenterology 1998; 114: A970.
12. Kamen BA. Takach PL. Vatev R. Caston JD. A rapid, radio chemical-ligand binding assay for methotrexate. Anal Biochem 1976; 70: 54-63.
13. Bischoff KB, Dedrick RL, Zaharko DS, Longstreth JA. Methotrexate pharmacokinetics. J Pharm Sci 1971; 60: 1128-33.
14. McAnena OJ, Rossi M, Mehta BM, Daly JM. Alteration of methotrexate metabolism in rats by administration of an elemental liquid diet. I. Changes in drug enterohepatic circulation. Cancer 1987; 59: 31-7.
15. Chu E, Allegra CJ. Antifolates. In: Chabner BA. Longo DL. eds. Cancer Chemotherapy and Biotherapy. 2nd edn. Philadelphia: Lippincott-Raven. 1996; 109-48.
16. Balis FM, Savitch JL, Bleyer WA. Pharmacokineties of oral methotrexate in children. Cancer Res 1983; 43: 2342-5.